Tablet or capsule form of generic mycophenolate mofetil (My-Rept(®)) after liver transplantation: a prospective randomized trial

BACKGROUND: Tablet and capsule forms have advantages and disadvantages in the market. Generally, the tablet form (500 mg) of mycophenolate mofetil (MMF) is more convenient for drug ingestion and more cost-effective than the capsule form (250 mg). We examined the efficacy and safety of MMF in its dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong Man, Oh, Jong Wook, Kim, Sangjin, Rhu, Jinsoo, Lee, Ji Soo, Kim, Kyeong Sik, Choi, Gyu-Seong, Joh, Jae-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617558/
https://www.ncbi.nlm.nih.gov/pubmed/31308630
http://dx.doi.org/10.2147/DDDT.S204056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617558/
https://www.ncbi.nlm.nih.gov/pubmed/31308630
http://dx.doi.org/10.2147/DDDT.S204056

Ejemplares similares